ReviewThe EPMA journal2025

Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management.

Salem Baldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.